ArticleTherapeutic advances in musculoskeletal disease2026
Efficacy and safety of dual-targeted therapy with tofacitinib and TNF inhibitors in refractory spondyloarthritis: a case series from a tertiary care center.
Aashish Agrawal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.